Literature DB >> 17890787

Ascites in cirrhosis: a review of management and complications.

J J Kuiper1, H R van Buuren, R A de Man.   

Abstract

Ascites is the most common manifestation in cirrhotic patients, and is associated with a reduced survival rate. Management of ascites is primarily focused on sodium restriction and diuretic treatment to which most patients respond appropriately. For the small group of patients who do not respond sufficiently, interventions such as large volume paracentesis and transjugular intrahepatic portosystemic shunt placement should be considered. Most important in the management of cirrhotic patients with ascites is prevention of complications. Spontaneous bacterial peritonitis and hepatorenal syndrome are severe complications with a poor prognosis when not detected and treated in an early stage. In all hospitalised patients with ascites, an infection of the ascitic fluid should be ruled out. For those patients at risk of developing spontaneous bacterial peritonitis, in particular patients after a first episode and patients with gastrointestinal bleeding, antibiotic prophylaxis should be given. To prevent the hepatorenal syndrome, substitution with albumin is essential, both in patients who experience an episode of spontaneous bacterial peritonitis and in patients treated with large volume paracentesis. For those patients unresponsive to standard treatment regimens, liver transplantation may be the only suitable treatment option.

Entities:  

Mesh:

Year:  2007        PMID: 17890787

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  7 in total

1.  Automated low flow pump system for the treatment of refractory ascites: a single-center experience.

Authors:  M N Thomas; G H Sauter; A L Gerbes; M Stangl; T S Schiergens; M Angele; J Werner; M Guba
Journal:  Langenbecks Arch Surg       Date:  2015-11-13       Impact factor: 3.445

Review 2.  Inflammatory status in human hepatic cirrhosis.

Authors:  María Martínez-Esparza; María Tristán-Manzano; Antonio J Ruiz-Alcaraz; Pilar García-Peñarrubia
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

3.  Ascites drainage leading to intestinal adhesions at the mesentery of the small intestine with fatal outcome.

Authors:  B Kettler; H Schrem; J Klempnauer; G Grannas
Journal:  Clin Med Insights Case Rep       Date:  2014-01-12

4.  Conservative treatment versus elective repair of umbilical hernia in patients with liver cirrhosis and ascites: results of a randomized controlled trial (CRUCIAL trial).

Authors:  B de Goede; M M J van Rooijen; B J H van Kempen; W G Polak; R A de Man; P Taimr; J F Lange; H J Metselaar; G Kazemier
Journal:  Langenbecks Arch Surg       Date:  2020-11-25       Impact factor: 3.445

5.  MELD Score Is Not Related to Spontaneous Bacterial Peritonitis.

Authors:  Luciana Haddad; Tatiana Morgado Conte; Liliana Ducatti; Lucas Nacif; Luiz Augusto Carneiro D'Albuquerque; Wellington Andraus
Journal:  Gastroenterol Res Pract       Date:  2015-07-01       Impact factor: 2.260

6.  The impact of paracentesis flow rate in patients with liver cirrhosis on the development of paracentesis induced circulatory dysfunction.

Authors:  Maha Mohammad Elsabaawy; Shimaa Rashad Abdelhamid; Ayman Alsebaey; Eman Abdelsamee; Manar Abdelaal Obada; Tary Abdelhamid Salman; Eman Rewisha
Journal:  Clin Mol Hepatol       Date:  2015-12-24

7.  Long-term administration of Tolvaptan to patients with decompensated cirrhosis.

Authors:  Kengo Kanayama; Tetsuhiro Chiba; Kazufumi Kobayashi; Keisuke Koroki; Susumu Maruta; Hiroaki Kanzaki; Yuko Kusakabe; Tomoko Saito; Soichiro Kiyono; Masato Nakamura; Sadahisa Ogasawara; Eiichiro Suzuki; Yoshihiko Ooka; Shingo Nakamoto; Shin Yasui; Tatsuo Kanda; Hitoshi Maruyama; Jun Kato; Naoya Kato
Journal:  Int J Med Sci       Date:  2020-03-15       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.